Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $592,901 - $682,814
-4,100 Reduced 63.84%
2,322 $370,000
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $134,210 - $153,930
1,000 Added 18.44%
6,422 $862,000
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $433,158 - $537,427
-3,282 Reduced 37.71%
5,422 $879,000
Q4 2021

Jan 19, 2022

SELL
$107.43 - $135.93 $3,222 - $4,077
-30 Reduced 0.34%
8,704 $1.18 Million
Q3 2021

Oct 20, 2021

BUY
$106.4 - $120.78 $21,280 - $24,156
200 Added 2.34%
8,734 $942,000
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $434,517 - $484,077
-4,130 Reduced 32.61%
8,534 $961,000
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $668,837 - $736,309
6,538 Added 106.73%
12,664 $1.37 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $493,081 - $665,712
6,126 New
6,126 $656,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Signature Wealth Management Partners, LLC Portfolio

Follow Signature Wealth Management Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Wealth Management Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Wealth Management Partners, LLC with notifications on news.